M+W Group acquires LifeTek Solutions in America

The global engineering and construction company M+W Group has announced

that their operations in the Americas have acquired 100% ownership of LifeTek

Solutions, Inc. With this acquisition, M+W Americas also obtains LifeTek’s

25% share in the exclusive SmartFit Modular BioSuites and FillSuites.

LifeTek’s team of industry recognized experts specialize in developing technically

driven projects in the pharmaceutical and biotechnology communities. Adept in the

design of equipment and arrangements for these projects, the LifeTek team has the

operating, maintenance, design, construction, and qualification background that

founds a thorough understanding of how best to compose a manufacturing process

and ensure their customers success. Their exclusive SmartFit modular BioSuites

and FillSuites cut delivery time in half while providing proven field-tested

performance.

“Emerging technologies in the Life Science industries are transforming the way

therapeutics are manufactured. The synergy between M+W Group and LifeTek will

bring a world of innovative technology and expertise to our clients, assisting them to

embrace new processes and streamline project delivery.” said Rick Whitney,

President and CEO of M+W Americas.

“We are very excited about this acquisition.” commented George Wiker, Principal of

LifeTek. “Together, M+W Group and LifeTek will provide customers with unmatched

engineering depth in a single-firm solution from concept to start-up.”

About M+W Group (www.mwgroup.net): M+W Group is the leading global engineering,

construction and project management company in the fields of Advanced Technology

Facilities, Life Science & Chemicals, Energy & Environment Technologies and High-Tech

Infrastructure. From concept development to turnkey services the company manages projects

of all sizes ensuring rapid realization, high quality standards and cost-effective completion.

With its competence to link process and automation technologies and complex facilities to

integrated solutions M+W Group primarily focuses on leading companies in the fields of

electronics, photovoltaics, life science, chemicals, energy, automotive, security and

communication, as well as research institutes and universities. M+W Group is the holding

company with headquarters in Stuttgart, Germany. In 2011 the company generated an order

intake of $3.6 billion and revenues of $3.5 billion with more than 7,000 employees. In 2012

M+W Group celebrated its 100th anniversary.

M+W Group is owned by the Austrian Stumpf Group that is globally successful in the areas of

High-Tech Engineering, Smart & Renewable Energy, Real Estate and Technology

Investments.

About LifeTek (www.lifetek.com): LifeTek is a design and consulting team who work to help

BioPharm companies succeed in developing processes, build manufacturing capacity as well

as establish & maintain compliance. LIFETEK focuses exclusively on pharmaceutical and

biological projects with a strong understanding that the design of a pharmbio project begins

with the process, whether it is a laboratory, pilot plant, or full scale manufacturing

facility. LifeTek’s philosophy is to provide a unique solution to the needs of its client base by

providing standard and validateable process designs and process systems to improve

delivery, reduce cost and assure successful startup while minimizing risk.

About SmartFit Modular (www.smartFit.com): SmartFit Modular offers complete

bioprocessing and aseptic filling suites which can be erected within an existing building,

anywhere in the world. SmartFit suites can accommodate projects from development through

market launch. The affordable solution can speed the rate of return on the investment.

Source: M+W Group

As the healthcare landscape continues to evolve, IMEG’s healthcare leaders from across the country are seeing several emerging trends that are poised to have wide-ranging impacts on facility design and construction. Following are six of the trends and strategies they expect to become more commonplace in 2022 and the years to come.